Anavex Life Sciences Corp (AVXL)

[BeingReal]

You seem to be making my point..

I see serious implications in pursuing the path of "switching" a patient to an unapproved mono-therapy -- "efficacy" has not been established! Anavex would, in my opinion, be foolish to "switch" patients to the mono-therapy and announce it to the world as you say.

After all the speculation of patients being switched to mono resulting in the uptrend, I believe it's possible the uptrend is due to time on the original therapy. What say you?